Journal Mobile Options
Table of Contents
Vol. 13, No. 4, 2010
Issue release date: April 2010
Public Health Genomics 2010;13:256–266
(DOI:10.1159/000279627)

On Track? Using the Human Genome Epidemiology Roadmap

Little J. · Hawken S.
Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ont., Canada

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

This paper considers the potential value of genomic information, comments on the nature of evidence about this potential value, particularly on genetic association studies, points out the need for a roadmap, outlines steps in a roadmap that was developed within the Human Genome Epidemiology Network (HuGENet), discusses progress with these steps, and comments on future directions.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K: Environmental and heritable factors in the causation of cancer – analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000;343:78–85.
  2. Aaltonen L, Johns L, Jarvinen H, Mecklin JP, Houlston R: Explaining the familial colorectal cancer risk associated with mismatch repair (MMR)-deficient and MMR-stable tumors. Clin Cancer Res 2007;13:356–361.
  3. Collins FS, Green ED, Guttmacher AE, Guyer MS: A vision for the future of genomics research. Nature 2003;422:835–847.
  4. Davey Smith G, Ebrahim S: ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003;32:1–22.
  5. Davey Smith G, Ebrahim S: What can Mendelian randomisation tell us about modifiable behavioural and environmental exposures? BMJ 2005;330:1076–1079.
  6. Sheehan NA, Didelez V, Burton PR, Tobin MD: Mendelian randomisation and causal inference in observational epidemiology. PLoS Med 2008;5:e177.
  7. Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G: Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 2008;27:1133–1163.
  8. Collins FS: Shattuck lecture – medical and societal consequences of the human genome project. N Engl J Med 1999;341:28–37.
  9. Collins FS, Guttmacher AE: Genetics moves into the medical mainstream. JAMA 2001;286:2322–2324.
  10. Khoury MJ, Little J, Burke W: Human genome epidemiology: scope and strategies; in Khoury MJ, Little J, Burke W (eds): Human Genome Epidemiology. New York, Oxford University Press, 2004, pp 3–16.
  11. Nebert DW, Jorge-Nebert L, Vesell ES: Pharmacogenomics and ‘individualized drug therapy’: high expectations and disappointing achievements. Am J Pharmacogenomics 2003;3:361–370.
  12. Little J, Sharp L, Khoury MJ, Bradley L, Gwinn M: The epidemiologic approach to pharmacogenomics. Am J Pharmacogenomics 2005;5:1–20.
  13. Holtzman NA, Marteau TM: Will genetics revolutionize medicine? N Engl J Med 2000;343:141–144.
  14. Willett WC: Balancing life-style and genomics research for disease prevention. Science 2002;296:695–698.
  15. Vineis P, Schulte P, McMichael AJ: Misconceptions about the use of genetic tests in populations. Lancet 2001;357:709–712.
  16. Khoury MJ, Yang Q, Gwinn M, Little J, Flanders WD: An epidemiologic assessment of genomic profiling for measuring susceptibility to common diseases and targeting interventions. Genet Med 2004;6:38–47.
  17. Madlensky L, McLaughlin JR, Carroll JC, Goel V, Frank JW: Risks and benefits of population-based genetic testing for Mendelian subsets of common diseases were examined using the example of colorectal cancer risk. J Clin Epidemiol 2005;58:934–941.
  18. Janssens AC, Gwinn M, Bradley LA, Oostra BA, van Duijn CM, Khoury MJ: A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions. Am J Hum Genet 2008;82:593–599.
  19. Yang Q, Khoury MJ, Botto L, Friedman JM, Flanders WD: Improving the prediction of complex diseases by testing for multiple disease-susceptibility genes. Am J Hum Genet 2003;72:636–649.
  20. Yang Q, Khoury MJ, Friedman JM, Little J, Flanders WD: How many genes underlie the occurrence of common complex diseases in the population? Int J Epidemiol 2005;34:1129–1137.
  21. Caulfield TA, Burgess MM, Williams-Jones B, Baily MA, Chadwick R, Cho M, Deber R, Fleising U, Flood C, Friedman J, Lank R, Owen T, Sproule J: Providing genetic testing through the private sector – a view from Canada. Can J Policy Res 2001;2:72–81.
  22. Gollust SE, Wilfond BS, Hull SC: Direct-to-consumer sales of genetic services on the Internet. Genet Med 2003;5:332–337.
  23. Williams-Jones B: Where there’s a web, there’s a way: commercial genetic testing and the Internet. Community Genet 2003;6:46–57.
  24. Human Genetics Commission: Genes direct. Ensuring the effective oversight of genetic tests supplied directly to the public. London, Department of Health, 2003.
  25. Gray S, Olopade OI: Direct-to-consumer marketing of genetic tests for cancer: buyer beware. J Clin Oncol 2003;21:3191–3193.
  26. McCabe LL, McCabe ER: Direct-to-consumer genetic testing: access and marketing. Genet Med 2004;6:58–59.
  27. American College of Medicine Genetics Board of Directors: ACMG statement on direct-to-consumer genetic testing. Genet Med 2004;6:60.

    External Resources

  28. Kutz G: Nutrigenetic testing. Tests purchased from four web sites mislead consumers. Washington, DC, United States Government Accountability Office, 2006.
  29. Hardy J, Singleton A: Genomewide association studies and human disease. N Engl J Med 2009;360:1759–1768.
  30. Salinas CA, Koopmeiners JS, Kwon EM, FitzGerald L, Lin DW, Ostrander EA, Feng Z, Stanford JL: Clinical utility of five genetic variants for predicting prostate cancer risk and mortality. Prostate 2009;69:363–372.
  31. Lango H, UK Type 2 Diabetes Genetics Consortium, Palmer CN, Morris AD, Zeggini E, Hattersley AT, McCarthy MI, Frayling TM, Weedon MN: Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk. Diabetes 2008;57:3129–3135.
  32. Jakobsdottir J, Gorin MB, Conley YP, Ferrell RE, Weeks DE: Interpretation of genetic association studies: markers with replicated highly significant odds ratios may be poor classifiers. PLoS Genet 2009;5:e1000337.
  33. Khoury MJ, McBride C, Schully SD, Ioannidis JP, Feero WG, Janssens AC, Gwinn M, Simons-Morton DG, Bernhardt JM, Cargill M, Chanock SJ, Church GM, Coates RJ, Collins FS, Croyle RT, Davis BR, Downing GJ, Duross A, Friedman S, Gail MH, Ginsburg GS, Green RC, Greene MH, Greenland P, Gulcher JR, Hsu A, Hudson KL, Kardia SL, Kimmel PL, Lauer MS, Miller AM, Offit K, Ransohoff DF, Roberts JS, Rasooly RS, Stefansson K, Terry SF, Teutsch SM, Trepanier A, Wanke KL, Witte JS, Xu J; Centers for Disease Control and Prevention: The Scientific Foundation for Personal Genomics: Recommendations from a National Institutes of Health-Centers for Disease Control and Prevention Multidisciplinary Workshop. Genet Med 2009;11:559–567.
  34. Berwick DM: Disseminating innovations in health care. JAMA 2003;289:1969–1975.
  35. Greenhalgh T, Robert G, Macfarlane F, Bate P, Kyriakidou O: Diffusion of innovations in service organizations: systematic review and recommendations. Milbank Q 2004;82:581–629.
  36. Thomas DC: Statistical Methods in Genetic Epidemiology. New York, Oxford University Press, 2004.
  37. Risch N, Merikangas K: The future of genetic studies of complex human diseases. Science 1996;273:1516–1517.
  38. McCarthy MI, Abecasis GR, Cardon LR, Goldstein DB, Little J, Ioannidis JP, Hirschhorn JN: Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 2008;9:356–369.
  39. Pearson TA, Manolio TA: How to interpret a genome-wide association study. JAMA 2008;299:1335–1344.
  40. Lawrence RW, Evans DM, Cardon LR: Prospects and pitfalls in whole genome association studies. Philos Trans R Soc Lond B Biol Sci 2005;360:1589–1595.
  41. Thomas DC: Are we ready for genome-wide association studies? Cancer Epidemiol Biomarkers Prev 2006;15:595–598.
  42. Lin BK, Clyne M, Walsh M, Gomez O, Yu W, Gwinn M, Khoury MJ: Tracking the epidemiology of human genes in the literature: the HuGE published literature database. Am J Epidemiol 2006;164:1–4.
  43. Yu Y, Yesupriya A, Clyne M, Wulf A, Gwinn M, Khoury MJ: HuGE Literature Finder. HuGE Navigator. 2008. Available at http://www.hugenavigator.net/HuGENavigator/searchSummary.do?firstQuery=Gene-disease+association&publitSearchType=now &whichContinue=firststart&check=n &dbType=publit&Mysubmit=go (accessed December 15, 2008).
  44. Manolio TA, Brooks LD, Collins FS: A HapMap harvest of insights into the genetics of common disease. J Clin Invest 2008;118:1590–1605.
  45. Donnelly J: ‘Yuppie scans’ unethical marketing ploy, radiologist says. CMAJ 2003;168:1167.
  46. Genome-based research and population health international network (GRaPH Int). Montreal, Public Health Agency of Canada, 2008. Available at http://www.graphint.org/ver2/ (accessed May 26, 2008).
  47. Anonymous: Freely associating (editorial). Nat Genet 1999;22:1–2.
  48. Gambaro G, Anglani F, D’Angelo A: Association studies of genetic polymorphisms and complex disease. Lancet 2000;355:308–311.
  49. Cardon L, Bell J: Association study designs for complex diseases. Nat Rev Genet 2001;2:91–99.
  50. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ionnadis DG: Replication validity of genetic association studies. Nat Genet 2001;29:306–309.
  51. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K: A comprehensive review of genetic association studies. Genet Med 2002;4:45–61.
  52. Tabor HK, Risch NJ, Myers RM: Opinion: candidate-gene approaches for studying complex genetic traits: practical considerations. Nat Rev Genet 2002;3:391–397.
  53. In search of genetic precision. Lancet 2003;361:357.
  54. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN: Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003;33:177–182.
  55. Gorroochurn P, Hodge SE, Heiman GA, Durner M, Greenberg DA: Non-replication of association studies: ‘pseudo-failures’ to replicate? Genet Med 2007;9:325–331.
  56. Taubes G: Epidemiology faces its limits. Science 1995;269:164–169.
  57. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB: Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 2000;283:2008–2012.
  58. Little J, Khoury MJ, Bradley L, Clyne M, Gwinn M, Lin B, Lindegren ML, Yoon P: The human genome project is complete. How do we develop a handle for the pump? Am J Epidemiol 2003;157:667–673.
  59. Ioannidis JP, Bernstein J, Boffetta P, Danesh J, Dolan S, Hartge P, Hunter D, Inskip P, Jarvelin MR, Little J, Maraganore DM, Bishop JA, O’Brien TR, Petersen G, Riboli E, Seminara D, Taioli E, Uitterlinden AG, Vineis P, Winn DM, Salanti G, Higgins JP, Khoury MJ: A network of investigator networks in human genome epidemiology. Am J Epidemiol 2005;162:302–304.
  60. Ioannidis JP, Gwinn M, Little J, Higgins JP, Bernstein JL, Boffetta P, Bondy M, Bray MS, Brenchley PE, Buffler PA, Casas JP, Chokkalingam A, Danesh J, Smith GD, Dolan S, Duncan R, Gruis NA, Hartge P, Hashibe M, Hunter DJ, Jarvelin MR, Malmer B, Maraganore DM, Newton-Bishop JA, O’Brien TR, Petersen G, Riboli E, Salanti G, Seminara D, Smeeth L, Taioli E, Timpson N, Uitterlinden AG, Vineis P, Wareham N, Winn DM, Zimmern R, Khoury MJ; Human Genome Epidemiology Network and the Network of Investigator Networks: A road map for efficient and reliable human genome epidemiology. Nat Genet 2006;38:3–5.
  61. De Angelis C, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, Kotzin S, Laine C, Marusic A, Overbeke AJ, Schroeder TV, Sox HC, Van Der Weyden MB; International Committee of Medical Journal Editors: Clinical trial registration: a statement from the International Committee of Medical Journal Editors. CMAJ 2004;171:606–607.
  62. Burton PR, Hansell AL, Fortier I, Manolio TA, Khoury MJ, Little J, Elliott P: Size matters: just how big is BIG? Quantifying realistic sample size requirements for human genome epidemiology. Int J Epidemiol 2009;38:263–273.
  63. Seminara D, Khoury MJ, O’Brien TR, Manolio T, Gwinn ML, Little J, Higgins JP, Bernstein JL, Boffetta P, Bondy M, Bray MS, Brenchley PE, Buffler PA, Casas JP, Chokkalingam AP, Danesh J, Davey Smith G, Dolan S, Duncan R, Gruis NA, Hashibe M, Hunter D, Jarvelin MR, Malmer B, Maraganore DM, Newton-Bishop JA, Riboli E, Salanti G, Taioli E, Timpson N, Uitterlinden AG, Vineis P, Wareham N, Winn DM, Zimmern R, Ioannidis JP; Human Genome Epidemiology Network; Network of Investigator Networks: The emergence of networks in human genome epidemiology: challenges and opportunities. Epidemiology 2007;18:1–8.
  64. Homer N, Szelinger S, Redman M, Duggan D, Tembe W, Muehling J, Pearson JV, Stephan DA, Nelson SF, Craig DW: Resolving individuals contributing trace amounts of DNA to highly complex mixtures using high-density SNP genotyping microarrays. PLoS Genet 2008;4:e1000167.
  65. Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, von Elm E, Khoury MJ, Cohen B, Davey-Smith G, Grimshaw J, Scheet P, Gwinn M, Williamson RE, Zou GY, Hutchings K, Johnson CY, Tait V, Wiens M, Golding J, van Duijn C, McLaughlin J, Paterson A, Wells G, Fortier I, Freedman M, Zecevic M, King R, Infante-Rivard C, Stewart AF, Birkett N: Strengthening the reporting of genetic association studies (STREGA): an extension of the strengthening the reporting of observational studies in epidemiology (STROBE) statement. J Clin Epidemiol 2009;62(suppl e4):597–608.

    External Resources

  66. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative: The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007;370:1453–1457.
  67. AlJasir B: Assessment of systematic effects of methodological characteristics on genetic associations; thesis, University of Ottawa, Ottawa, 2009.
  68. Kavvoura FK, Ioannidis JP: Methods for meta-analysis in genetic association studies: a review of their potential and pitfalls. Hum Genet 2008;123:1–14.
  69. Sagoo GS, Little J, Higgins JP: Systematic reviews of genetic association studies. Human genome epidemiology network. PLoS Med 2009;6:e28.
  70. Houlston RS, Webb E, Broderick P, Pittman AM, Di Bernardo MC, Lubbe S, Chandler I, Vijayakrishnan J, Sullivan K, Penegar S; Colorectal Cancer Association Study Consortium, Carvajal-Carmona L, Howarth K, Jaeger E, Spain SL, Walther A, Barclay E, Martin L, Gorman M, Domingo E, Teixeira AS; CoRGI Consortium, Kerr D, Cazier JB, Niittymäki I, Tuupanen S, Karhu A, Aaltonen LA, Tomlinson IP, Farrington SM, Tenesa A, Prendergast JG, Barnetson RA, Cetnarskyj R, Porteous ME, Pharoah PD, Koessler T, Hampe J, Buch S, Schafmayer C, Tepel J, Schreiber S, Völzke H, Chang-Claude J, Hoffmeister M, Brenner H, Zanke BW, Montpetit A, Hudson TJ, Gallinger S; International Colorectal Cancer Genetic Association Consortium, Campbell H, Dunlop MG: Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nat Genet 2008;40:1426–1435.
  71. Zeggini E, Scott LJ, Saxena R, Voight BF, Marchini JL, Hu T, de Bakker PI, Abecasis GR, Almgren P, Andersen G, Ardlie K, Boström KB, Bergman RN, Bonnycastle LL, Borch-Johnsen K, Burtt NP, Chen H, Chines PS, Daly MJ, Deodhar P, Ding CJ, Doney AS, Duren WL, Elliott KS, Erdos MR, Frayling TM, Freathy RM, Gianniny L, Grallert H, Grarup N, Groves CJ, Guiducci C, Hansen T, Herder C, Hitman GA, Hughes TE, Isomaa B, Jackson AU, Jørgensen T, Kong A, Kubalanza K, Kuruvilla FG, Kuusisto J, Langenberg C, Lango H, Lauritzen T, Li Y, Lindgren CM, Lyssenko V, Marvelle AF, Meisinger C, Midthjell K, Mohlke KL, Morken MA, Morris AD, Narisu N, Nilsson P, Owen KR, Palmer CN, Payne F, Perry JR, Pettersen E, Platou C, Prokopenko I, Qi L, Qin L, Rayner NW, Rees M, Roix JJ, Sandbaek A, Shields B, Sjögren M, Steinthorsdottir V, Stringham HM, Swift AJ, Thorleifsson G, Thorsteinsdottir U, Timpson NJ, Tuomi T, Tuomilehto J, Walker M, Watanabe RM, Weedon MN, Willer CJ; Wellcome Trust Case Control Consortium, Illig T, Hveem K, Hu FB, Laakso M, Stefansson K, Pedersen O, Wareham NJ, Barroso I, Hattersley AT, Collins FS, Groop L, McCarthy MI, Boehnke M, Altshuler D: Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 2008;40:638–645.
  72. Marchini J, Howie B: Comparing algorithms for genotype imputation. Am J Hum Genet 2008;83:535–539.
  73. Davey Smith G, Ebrahim S: ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003;32:1–22.
  74. Ioannidis JP, Boffetta P, Little J, O’Brien TR, Uitterlinden AG, Vineis P, Balding DJ, Chokkalingam A, Dolan SM, Flanders WD, Higgins JP, McCarthy MI, McDermott DE, Page GP, Rebbeck TR, Seminara D, Khoury MJ: Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol 2008;37:120–132.
  75. Anonymous: Embracing risk (editorial). Nat Genet 2006;38:1.
  76. Allen NC, Bagade S, McQueen MB, Ioannidis JP, Kavvoura FK, Khoury MJ, Tanzi RE, Bertram L: Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet 2008;40:827–834.
  77. Vineis P, Manuguerra M, Kavvoura FK, Guarrera S, Allione A, Rosa F, Di Gregorio A, Polidoro S, Saletta F, Ioannidis JP, Matullo G: A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility. J Natl Cancer Inst 2009;101:24–36.
  78. Zintzaras E, Zdoukopoulos N: A field synopsis and meta-analysis of genetic association studies in peripheral arterial disease: the CUMAGAS-PAD database. Am J Epidemiol 2009;170:1–11.
  79. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, McCarthy MI, Ramos EM, Cardon LR, Chakravarti A, Cho JH, Guttmacher AE, Kong A, Kruglyak L, Mardis E, Rotimi CN, Slatkin M, Valle D, Whittemore AS, Boehnke M, Clark AG, Eichler EE, Gibson G, Haines JL, Mackay TF, McCarroll SA, Visscher PM: Finding the missing heritability of complex diseases. Nature 2009;461:747–753.
  80. Zhu X, Feng T, Li Y, Lu Q, Elston RC: Detecting rare variants for complex traits using family and unrelated data. Genet Epidemiol 2010;34:171–187.
  81. Wain LV, Armour JA, Tobin MD: Genomic copy number variation, human health, and disease. Lancet 2009;374:340–350.
  82. Tucker T, Marra M, Friedman JM: Massively parallel sequencing: the next big thing in genetic medicine. Am J Hum Genet 2009;85:142–154.
  83. Quackenbush J: Microarray analysis and tumor classification. N Engl J Med 2006;354:2463–2472.
  84. Widschwendter M, Apostolidou S, Raum E, Rothenbacher D, Fiegl H, Menon U, Stegmaier C, Jacobs IJ, Brenner H: Epigenotyping in peripheral blood cell DNA and breast cancer risk: a proof of principle study. PLoS One 2008;3:e2656.
  85. Kaminsky ZA, Tang T, Wang SC, Ptak C, Oh GH, Wong AH, Feldcamp LA, Virtanen C, Halfvarson J, Tysk C, McRae AF, Visscher PM, Montgomery GW, Gottesman II, Martin NG, Petronis A: DNA methylation profiles in monozygotic and dizygotic twins. Nat Genet 2009;41:240–245.
  86. Slatkin M: Epigenetic inheritance and the missing heritability problem. Genetics 2009;182:845–850.
  87. Jablonka E, Raz G: Transgenerational epigenetic inheritance: prevalence, mechanisms, and implications for the study of heredity and evolution. Q Rev Biol 2009;84:131–176.
  88. Diamandis EP, van der Merwe DE: Plasma protein profiling by mass spectrometry for cancer diagnosis: opportunities and limitations. Clin Cancer Res 2005;11:963–965.
  89. Nature Omics Gateway: Nature Publishing Group, 2009. Available at http://www.nature.com/omics/index.html (accessed November 16, 2009).
  90. Khoury MJ, Gwinn M, Yoon PW, Dowling N, Moore CA, Bradley L: The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med 2007;9:665–674.
  91. National Human Genome Research Institute: A catalog of published genome-wide association studies. 2009. Available at http://www.genome.gov/26525384 (accessed November 17, 2009).
  92. Ioannidis JP, Contopoulos-Ioannidis DG, Rosenberg PS, Goedert JJ, De Rossi A, Espanol T, Frenkel L, Mayaux MJ, Newell ML, Pahwa SG, Rousseau C, Scarlatti G, Sei S, Sen L, O’Brien TR; HIV Host Genetics International Meta-Analysis Group: Effects of CCR5-delta32 and CCR2–64I alleles on disease progression of perinatally HIV-1-infected children: an international meta-analysis. AIDS 2003;17:1631–1638.
  93. Petersen GM, de Andrade M, Goggins M, Hruban RH, Bondy M, Korczak JF, Gallinger S, Lynch HT, Syngal S, Rabe KG, Seminara D, Klein AP: Pancreatic cancer genetic epidemiology consortium. Cancer Epidemiol Biomarkers Prev 2006;15:704–710.
  94. Bernstein JL, Langholz B, Haile RW, Bernstein L, Thomas DC, Stovall M, Malone KE, Lynch CF, Olsen JH, Anton-Culver H, Shore RE, Boice JD Jr, Berkowitz GS, Gatti RA, Teitelbaum SL, Smith SA, Rosenstein BS, Børresen-Dale AL, Concannon P, Thompson WD; WECARE study: Study design: evaluating gene-environment interactions in the etiology of breast cancer – the WECARE study. Breast Cancer Res 2004;6:R199–R214.
  95. Figueiredo JC, Haile RW, Bernstein L, Malone KE, Largent J, Langholz B, Lynch CF, Bertelsen L, Capanu M, Concannon P, Borg A, Børresen-Dale AL, Diep A, Teraoka S, Torngren T, Xue S, Bernstein JL: Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers: the WECARE Study. Breast Cancer Res Treat 2009;120:175–183.
  96. Taioli E, Garza MA, Ahn YO, Bishop DT, Bost J, Budai B, Chen K, Gemignani F, Keku T, Lima CS, Le Marchand L, Matsuo K, Moreno V, Plaschke J, Pufulete M, Thomas SB, Toffoli G, Wolf CR, Moore CG, Little J: Meta- and pooled analyses of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and colorectal cancer: a HuGE-GSEC review. Am J Epidemiol 2009;170:1207–1221.
  97. Gaspari L, Marinelli D, Taioli E, Collaborative Group on Genetic Susceptibility to Environmental Carcinogens: International collaborative study on genetic susceptibility to environmental carcinogens (GSEC): an update. Int J Hyg Environ Health 2001;204:39–42.
  98. International networks/registries in human genome epidemiology: Department of Hygiene & Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece, 2007. Available at http://www.dhe.med.uoi.gr/networklist.php (accessed November 17, 2009).
  99. Karassa FB, Bijl M, Davies KA, Kallenberg CG, Khamashta MA, Manger K, Michel M, Piette JC, Salmon JE, Song YW, Tsuchiya N, Yoo DH, Ioannidis JP: Role of the Fcgamma receptor IIA polymorphism in the antiphospholipid syndrome: an international meta-analysis. Arthritis Rheum 2003;48:1930–1938.
  100. Genetic Epidemiology of Parkinson’s Disease Consortium (GEOPD): 4th Annual Meeting. 2009. Available at http://www.geopdmeeting2009.org/ (accessed November 17, 2009).
  101. Maraganore DM, de Andrade M, Elbaz A, Farrer MJ, Ioannidis JP, Krüger R, Rocca WA, Schneider NK, Lesnick TG, Lincoln SJ, Hulihan MM, Aasly JO, Ashizawa T, Chartier-Harlin MC, Checkoway H, Ferrarese C, Hadjigeorgiou G, Hattori N, Kawakami H, Lambert JC, Lynch T, Mellick GD, Papapetropoulos S, Parsian A, Quattrone A, Riess O, Tan EK, Van Broeckhoven C; Genetic Epidemiology of Parkinson’s Disease (GEO-PD) Consortium: Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA 2006;296:661–670.
  102. Fibrinogen Studies Collaboration: Collaborative meta-analysis of prospective studies of plasma fibrinogen and cardiovascular disease. Eur J Cardiovasc Prev Rehabil 2004;11:9–17.
  103. Fibrinogen Studies Collaboration, Jackson D, White I, Kostis JB, Wilson AC, Folsom AR, Wu K, Chambless L, Benderly M, Goldbourt U, Willeit J, Kiechl S, Yarnell JW, Sweetnam PM, Elwood PC, Cushman M, Psaty BM, Tracy RP, Tybjaerg-Hansen A, Haverkate F, de Maat MP, Thompson SG, Fowkes FG, Lee AJ, Smith FB, Salomaa V, Harald K, Rasi V, Vahtera E, Jousilahti P, D’Agostino R, Kannel WB, Wilson PW, Tofler G, Levy D, Marchioli R, Valagussa F, Rosengren A, Wilhelmsen L, Lappas G, Eriksson H, Cremer P, Nagel D, Curb JD, Rodriguez B, Yano K, Salonen JT, Nyyssönen K, Tuomainen TP, Hedblad B, Engström G, Berglund G, Loewel H, Koenig W, Hense HW, Meade TW, Cooper JA, De Stavola B, Knottenbelt C, Miller GJ, Cooper JA, Bauer KA, Rosenberg RD, Sato S, Kitamura A, Naito Y, Iso H, Salomaa V, Harald K, Rasi V, Vahtera E, Jousilahti P, Palosuo T, Ducimetiere P, Amouyel P, Arveiler D, Evans AE, Ferrieres J, Juhan-Vague I, Bingham A, Schulte H, Assmann G, Cantin B, Lamarche B, Despres JP, Dagenais GR, Tunstall-Pedoe H, Lowe GD, Woodward M, Ben-Shlomo Y, Davey Smith G, Palmieri V, Yeh JL, Meade TW, Rudnicka A, Brennan P, Knottenbelt C, Cooper JA, Ridker P, Rodeghiero F, Tosetto A, Shepherd J, Lowe GD, Ford I, Robertson M, Brunner E, Shipley M, Feskens EJ, Di Angelantonio E, Kaptoge S, Lewington S, Lowe GD, Sarwar N, Thompson SG, Walker M, Watson S, White IR, Wood AM, Danesh J: Systematically missing confounders in individual participant data meta-analysis of observational cohort studies. Stat Med 2009;28:1218–1237.
  104. Raimondi S, Pedotti P, Taioli E: APIKIDS: a cohort of children born after assisted reproductive technologies. Paediatr Perinat Epidemiol 2006;20:411–415.
  105. Felix AS, Bruinsma F, Klemetti R, Gissler M, Lerner-Geva L, Taioli E: International pooled analysis of cancer incidence in children after assisted reproductive technologies: interim report. Future Oncol 2009;5:901–906.
  106. Pennell CE, Jacobsson B, Williams SM, Buus RM, Muglia LJ, Dolan SM, Morken NH, Ozcelik H, Lye SJ; PREBIC Genetics Working Group, Relton C: Genetic epidemiologic studies of preterm birth: guidelines for research. Am J Obstet Gynecol 2007;196:107–118.
  107. van Meurs JB, Trikalinos TA, Ralston SH, Balcells S, Brandi ML, Brixen K, Kiel DP, Langdahl BL, Lips P, Ljunggren O, Lorenc R, Obermayer-Pietsch B, Ohlsson C, Pettersson U, Reid DM, Rousseau F, Scollen S, Van Hul W, Agueda L, Akesson K, Benevolenskaya LI, Ferrari SL, Hallmans G, Hofman A, Husted LB, Kruk M, Kaptoge S, Karasik D, Karlsson MK, Lorentzon M, Masi L, McGuigan FE, Mellström D, Mosekilde L, Nogues X, Pols HA, Reeve J, Renner W, Rivadeneira F, van Schoor NM, Weber K, Ioannidis JP, Uitterlinden AG; GENOMOS Study: Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis. JAMA 2008;299:1277–1290.
  108. Casas JP, Hingorani AD, Bautista LE, Sharma P: Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls. Arch Neurol 2004;61:1652–1661.
  109. Ariyaratnam R, Casas JP, Whittaker J, Smeeth L, Hingorani AD, Sharma P: Genetics of ischaemic stroke among persons of non-European descent: a meta-analysis of eight genes involving approximately 32,500 individuals. PLoS Med 2007;4:e131.
  110. Banerjee I, Gupta V, Ganesh S: Association of gene polymorphism with genetic susceptibility to stroke in Asian populations: a meta-analysis. J Hum Genet 2007;52:205–219.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50